Close

FibroGen (FGEN) Tops Q4 EPS by 21c

February 27, 2023 4:17 PM EST

FibroGen (NASDAQ: FGEN) reported Q4 EPS of ($0.70), $0.21 better than the analyst estimate of ($0.91). Revenue for the quarter came in at $34.37 million versus the consensus estimate of $24.05 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings